Screening for cervical cancer in prenatal care
DOI:
https://doi.org/10.33448/rsd-v10i14.22231Keywords:
Prenatal; Gestation; Pap test; Cervical neoplasms.Abstract
Considering that cervical cancer is a disease that can affect pregnant women in the same proportion as non-pregnant women, this study aimed to identify the factors that hinder the adherence of pregnant women to the examination during prenatal care, as that this is the most opportune time to do it. An integrative literature review was carried out, using articles available online in the Virtual Health Library (VHL) and in the National Library of Medicne (PubMed) published in the last 5 years, excluding theses, dissertations, duplicate articles and articles that did not fit the theme proposed. Four articles from the aforementioned database were selected to integrate this study. The articles selected for the construction of the work were read in full, in order to identify the factors that hinder adherence. It was possible to identify the low level of knowledge of pregnant women as a barrier, as most believe that the examination during pregnancy can be harmful to the baby or they do not know about what it prevents, believing that it is unnecessary. Other complicating factors were identified, demonstrating that most women are not suitable for the examination during prenatal care. Thus, it emphasizes the need for greater educational actions that help women to clarify the importance of performing the exam during the gestational period, benefiting them with regard to prevention and/or early detection of any abnormality.
References
Abdul, A.E., Mudau, T. S., & Chabedi, M. A. (2020). Perceptions of Midwives on Pap Smear Tests during Pregnancy. Asian Pacific Journal of Cancer Prevention, 21:3039. 10.31557/APJCP.2020.21.10.3039
Amant, F., Berveiller, P., Boere, I. A., Cardonick, E., Fruscio, R., Fumagalli, M. et al. (2019). Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. European Society for Medical Oncology, 30(10):1601-1612. 10.1093/annonc/mdz228.
Boldrini N. A. T., Rossi K. K. C, Sassine T. O. T., Filho H. Z. B., F& rizera H. C. (2019). Câncer do Colo do Útero na Gravidez. Femina. 47(1):55-60. https://docs.bvsalud.org/biblioref/2019/12/1046493/femina-2019-471-55-60.pdf
Brasil. Ministério da Saúde. Instituto Nacional de Câncer (INCA) (2020). O que é Câncer? https://www.inca.gov.br/o-que-e-cancer
Brasil. Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). (2019). Estimativa|2020 – Incidência de Câncer no Brasil. Rio de Janeiro (RJ). https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020- incidencia-de-cancer-no-brasil.pdf
Brasil. Ministério da Saúde. Instituto Nacional do Câncer (INCA). (2011). ABC do Câncer - Abordagens Básicas para o Controle do Câncer. Rio de Janeiro (RJ). https://bvsms.saude.gov.br/bvs/publicacoes/abc_do_cancer.pdf
Brasil. Ministério da Saúde. Instituto Nacional Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). (2016). Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero – 2ª edição revista, ampliada e atualizada. Rio de Janeiro (RJ). https://bvsms.saude.gov.br/bvs/publicacoes/inca/rastreamento_cancer_colo_utero.pdf
Brasil: Ministério da Saúde. Instituto Nacional de Câncer (INCA) (2021). Conceito e Magnitude. https://www.inca.gov.br/controle-do-cancer-do-colo-do-utero/fatores-de-risco
Brasil. Ministério da Saúde. Secretaria de Assistência à Saúde. Instituto Nacional do Câncer (INCA) (2002). Falando Sobre Câncer do Colo do Útero. Rio de Janeiro (RJ). https://bvsms.saude.gov.br/bvs/publicacoes/inca/falando_cancer_colo_utero.pdf
Cunha P. L. P., Cunha C. S., & Alves P. F. (2014). Manual revisão bibliográfica sistemática integrativa: a pesquisa baseada em evidências. Grupo Anima Educação. http://biblioteca.cofen.gov.br/wp-content/uploads/2019/06/manual_revisao_bibliografica-sistematica-integrativa.pdf
Gasparin V. A., Schmalfuss J. M., Zanotelli S. S., Silva E. F. (2020). Rastreamento do câncer de colo do útero durante o acompanhamento pré-natal. Rev. Eletr. Enferm, 22(63482):1-8. https://doi.org/10.5216/ree.v22.63482
Kuczbourska, K., Bartnik, J. K., Wolska, M., Pluta, M., Bartnik, P., Redo, A. D., & Wolniewicz, E. R. (2019). Secondary Cervical Cancer Prevention In Routine Prenatal Care — Coverage, Results And Lessons For The Future. Ginekologia Polska, 90(7). 10.5603/ GP.2019.0068
Moreira, R. C. R., Lopes, R. L. M., Peñarrieta, E. C. S., Gonzaga, R. J., Servo, M. L. S., & Nascimento, M. A. A. (2017). Abordagem fenomenológica do câncer de colo de útero em gestantes: aspectos da prevenção. Revista Cubana de Enfermería, 33(2):338-47. http://www.revenfermeria.sld.cu/index.php/enf/article/view/1159/264
Organização Pan-Americana da Saúde (2016). Controle Integral do Câncer do Colo do Útero – Guia de Práticas Essenciais. https://iris.paho.org/bitstream/handle/10665.2/31403/9789275718797-por.pdf
Rosa, A. R. R., Silva, T. S. L., Carvalho, I. C. S., Sousa, A. S. J., Rodrigues, A. B., & Penha, J. C. (2018). Exame Citopatológico do Colo do Útero: Investigação Sobre o Conhecimento, Atitude e Prática das Gestantes. Cogitare Enferm., (23)2:e52589. http://dx.doi.org/10.5380/ce.v23i2.52589
Suchonska B., Gajewska, M., Madej, A., & Wielgos, M. (2020). Cervical intraepithelial neoplasia during pregnancy. Indian Journal of Câncer, 57(1):31-35. 10.4103/ijc.IJC_403_18
Teixeira L. M., Santos A. A. P., Sanches M. E. T., L, Silva J. M. O., & Cavalcante M. V. (2019). Exame preventivo para o câncer de colo durante a gravidez: experiências das gestantes. Rev. Baiana Enferm, 33:e33698. 10.18471/rbe.v33.33698
Terlan R. J., & Cesar J. A. (2018). Não realização de citopatológico de colo uterino entre gestantes no extremo sul do Brasil: prevalência e fatores associados. Ciência & Saúde Coletiva, 23(11): 3557-3566. 10.1590/1413-812320182311.35162016
Tsuchiya C. T., Lawrence T., Klen M. S., Fernandes R. A., & Alves M. R. (2017). O Câncer de Colo de Útero no Brasil: Uma Retrospectiva Sobre as Políticas Públicas Voltadas à Saúde da Mulher. J Bras Econ Saúde, 9(1):137-147. 10.21115/JBES.v9.n1.p137-47
USA. National Cancer Institute (NIH) [homepage on the internet] (2021). Cervical Cancer Treatmente PDQ – Healt Professional Version. https://www.cancer.gov/types/cervical/hp/cervical-treatment-pdq
Wang, J., Elfstrom, K. M., Andrae, B., Kleppe, S. N., Ploner, A., Lei, J. et al. (2020). Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program. International Journal of Cancer, 146:1230-1240. 10.1002 / ijc.32416
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Isadora Fernanda Campos Nepomuceno; Anna Clara Araújo Moreira; Laís Rodrigues Souza ; Luísa Giarola Silva; Mírian de Sousa Borges; Silmara Nunes de Andrade
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
